Multiple myeloma (MM) is typically a disease of the elderly, with the median age at presentation being 65–70 years. MP-THAL (melphalan, prednisone–thalidomide), at the present time, represents the ...
No takes yet. Share an insight, caveat, or question.
Mele et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: